-Bloomberg
Oppenheimer Maintains Outperform on Ensign Group, Raises Price Target to $110
Oppenheimer analyst Colin Rusch maintains Ensign Group (NASDAQ:ENSG) with a Outperform and raises the price target from $105 to $110.
Related Posts
Piper Sandler Maintains Overweight on Bright Health Gr, Lowers Price Target to $3
Piper Sandler analyst Jeff Garro maintains Bright Health Gr (NYSE:BHG) with a Overweight and lowers the price target from $5 to $3.
AmeriCann Achieves All-Time Record Quarterly And Monthly Revenues, Here Are The Details
AmeriCann Inc. (OTCQB: ACAN) provided financial and operational updates for its Massachusetts cannabis cultivation, product manufacturing and distribution campus, revealing year-over-year quarterly revenue, increased over 36% for the quarter end
Insteel Indus Remains Cautiously Optimistic For FY24 As Customer Sentiment Is Mostly Positive, And Spending Associated With The Infrastructure Investment And Jobs Act Is Expected To Accelerate And Help Drive Demand
"In the wake of record financial results in the previous year, fiscal year 2023 presented a highly challenging business environment that required rebalancing our supply chain, a significant downward reset of steel